JCI Insight is an open access journal that has a 2019 Impact Factor of 6.205. The Journal publishes well-executed, high-quality studies that provide meaningful contributions to the understanding of the biology and/or treatment of disease, with an emphasis on clinically relevant basic and translational research. Submissions are welcome from all biomedical specialties, including Autoimmunity, Gastroenterology, Immunology, Metabolism, Nephrology, Neuroscience, Oncology, Pulmonology, Vascular Biology, and many others.
JCI Insight is self-published by the American Society for Clinical Investigation (ASCI), a nonprofit honor organization of physician-scientists established in 1908. JCI Insight serves to fulfill the ASCI’s objective to advance medical science through the publication of clinically relevant research reports. All articles published in JCI Insight are freely available online from the moment of publication. While all articles are freely available immediately upon publication, those published prior to August 20, 2020, may require permission for use; see License Information for details.
The Journal deposits published research articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.
JCI Insight meets cOAlition S requirements for authors who receive funding support from Plan S signatories and is fully compliant with HHMI, Wellcome, and UK Research and Innovation (UKRI) open access policies.
JCI Insight is headed by Editor in Chief Dr. Kathleen L. Collins, and manuscripts are adjudicated by our team of academic and professional editors. More information about the editors can be found here. In addition, the editors may seek the advice of members of our consulting editorial board.